What is the main business of Neoclinica?

The main business activity of Neoclinica focuses on hospital activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 20, 2016.

Where is the headquarters located?

The headquarters is located at: ul. Narcyzów 1, 41-205 Sosnowiec.

Who is on the management board?

The management board consists of: Jerzy Mariusz Wydmański (President of the Management Board) and Sławomir Maciej Wąchal (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 3,005,000 (approx. $811,723).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of USD 829 in 2025, which is an increase of 11.6% compared to 2024.

Is the company profitable?

No, the company recorded a net loss of USD 14,377 in 2025. For comparison, in 2024 the loss was USD 12,960, meaning the company increased its loss by 10.7%.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to USD 2,672 in 2025, representing 21% of all operating expenses.

Neoclinicasp. z o.o.

Hospital activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2016-01-20

Share capital

3 005 000,00 PLN

Activity description

NeoClinica sp. z o.o. based in Sosnowiec and NeoClinica sp. z o.o. sp.k. based in Sosnowiec operate this site with a notice about a planned merger of the companies. The announcement concerns the acquisition of the limited partnership by the limited liability company under the Polish Commercial Companies Code.

Registered address

ul. Narcyzów 1, 41-205 Sosnowiec, Poland

Website

neoclinica.pl

Financials

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 828.73MedianUSD 2.88mAverageUSD 12.29m

Net profit

This companyUSD -14.38kMedianUSD 51.95kAverageUSD 258.69k

Operating costs

This companyUSD 12.69kMedianUSD 2.60mAverageUSD 11.67m

Assets

This companyUSD 692.74kMedianUSD 2.06mAverageUSD 10.03m

News

2022-12-27

Announcement

Industry

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

Type	Amount
Land (incl. perpetual usufruct)	$9,368$9,368

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Jerzy Mariusz Wydmański – President of the Management Board

Sławomir Maciej Wąchal – Vice President of the Management Board

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, the President of the Management Board independently, or the Vice-President of the Management Board independently, or two other members of the management board jointly, or one other member of the management board jointly with a commercial proxy, is authorised to make declarations of will on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Beata Barabra Wydmańska	25	$337.66	0.0416%
Jerzy Mariusz Wydmański (60)	25	$337.66	0.0416%
Others	60,050	$811,048.08	99.9168%

Beneficial owners

Person	Rights

Competitors

	Name	Revenue	Website
	Regenerumclinicsp. z o.o.	$1,427.86	regenerumclinic.pl

Change history

Date	Event
2024-09-05	Share capital change (5,000.00 PLN → 3,005,000.00 PLN)
2016-01-20	Entered in the register

FAQ

Last updated: 2026-10-03